Table S3 from Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis
Year: 2023
Type: other
Abstract: Preliminary analysis of combining minocycline and irinotecan regimen indicates significant cost savings compared to other irinotecan-based combination therapies.
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362485466
